Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Max W Richardson"'
Autor:
Rachel S Leibman, Max W Richardson, Christoph T Ellebrecht, Colby R Maldini, Joshua A Glover, Anthony J Secreto, Irina Kulikovskaya, Simon F Lacey, Sarah R Akkina, Yanjie Yi, Farida Shaheen, Jianbin Wang, Keith A Dufendach, Michael C Holmes, Ronald G Collman, Aimee S Payne, James L Riley
Publikováno v:
PLoS Pathogens, Vol 13, Iss 10, p e1006613 (2017)
HIV is adept at avoiding naturally generated T cell responses; therefore, there is a need to develop HIV-specific T cells with greater potency for use in HIV cure strategies. Starting with a CD4-based chimeric antigen receptor (CAR) that was previous
Externí odkaz:
https://doaj.org/article/942f579e40144a97893d9fb154526278
Autor:
M. Angela Aznar, Charly R. Good, Shunichiro Kuramitsu, Parisa Samareh, Sangya Agarwal, Greg Donahue, Kenichi Ishiyama, Nils Wellhausen, Austin K. Rennels, Yujie Ma, Lifeng Tian, Sonia Guedan, Katherine A. Alexander, Zhen Zhang, Philipp C. Rommel, Nathan Singh, Karl M. Glastad, Max W. Richardson, Keisuke Watanabe, Janos L. Tanyi, Mark H. O’Hara, Marco Ruella, Simon F. Lacey, Edmund K. Moon, Stephen J. Schuster, Steven M. Albelda, Lewis L. Lanier, Regina M. Young, Shelley L. Berger, Carl H. June
Publikováno v:
Cancer Research. 82:3602-3602
Chimeric antigen receptor (CAR) T cell immunotherapy is FDA approved for the treatment of a subset of B cell malignancies but has shown limited clinical success in solid tumor therapy. T cell exhaustion is an important factor involved in treatment fa
Autor:
George J Leslie, Jianbin Wang, Max W Richardson, Beth S Haggarty, Kevin L Hua, Jennifer Duong, Anthony J Secreto, Andrea P O Jordon, Josephine Romano, Kritika E Kumar, Joshua J DeClercq, Philip D Gregory, Carl H June, Michael J Root, James L Riley, Michael C Holmes, James A Hoxie
Publikováno v:
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Externí odkaz:
https://doaj.org/article/b2848b8f422e4d1cb691aa0474392450
Autor:
Yujie Ma, Charly R. Good, Janos L. Tanyi, Carl H. June, Nathan Singh, Keisuke Watanabe, Lifeng Tian, Mark H. O'Hara, Shelley L. Berger, Shunichiro Kuramitsu, Lewis L. Lanier, Greg Donahue, Sangya Agarwal, Edmund K. Moon, Kenichi Ishiyama, M. Angela Aznar, Nils Wellhausen, Sonia Guedan, Marco Ruella, Stephen J. Schuster, Max W. Richardson, Steven M. Albelda, Parisa Samareh, Zhen Zhang, Regina M. Young, Katherine A. Alexander, Simon F. Lacey
Publikováno v:
Cancer Research. 81:60-60
Chimeric antigen receptor (CAR) T cell therapy has achieved remarkable success in hematological malignancies but remains largely ineffective in solid tumors. A major factor leading to the reduced efficacy of CAR T cell therapy is T cell dysfunction,
Autor:
Keisuke Watanabe, Charly R. Good, Kenichi Ishiyama, Greg Donahue, Marco Ruella, Lewis L. Lanier, Simon F. Lacey, Nathan Singh, Janos L. Tanyi, Austin K. Rennels, Shunichiro Kuramitsu, Yujie Ma, Lifeng Tian, Shelley L. Berger, Karl M. Glastad, Mark H. O'Hara, Regina M. Young, Parisa Samareh, Zhen Zhang, Edmund K. Moon, Carl H. June, M. Angela Aznar, Philipp C. Rommel, Steven M. Albelda, Katherine A. Alexander, Sangya Agarwal, Stephen J. Schuster, Max W. Richardson, Nils Wellhausen, Sonia Guedan
Publikováno v:
Cell
Summary Chimeric antigen receptor (CAR) T cell therapy has achieved remarkable success in hematological malignancies but remains ineffective in solid tumors, due in part to CAR T cell exhaustion in the solid tumor microenvironment. To study dysfuncti
Autor:
James L. Riley, Megan Estorninho, Lauren E. Nickolay, Timothy Tree, Caroline M. Hull, Max W. Richardson, John Maher, Mark Peakman
Publikováno v:
Hull, C M, Nickolay, L E, Estorninho, M, Richardson, M W, Riley, J L, Peakman, M, Maher, J & Tree, T I M 2017, ' Generation of human islet-specific regulatory T cells by TCR gene transfer ', Journal of Autoimmunity, vol. 79, pp. 63-73 . https://doi.org/10.1016/j.jaut.2017.01.001
Based on the success in animal models of type 1 diabetes (T1D), clinical trials of adoptive regulatory T cell (Treg) therapy are underway using ex vivo expanded polyclonal Tregs. However, pre-clinical data also demonstrate that islet-specific Tregs a
Autor:
James L. Riley, Ronald G. Collman, Joshua Glover, Simon F. Lacey, Christoph T. Ellebrecht, Keith A. Dufendach, Colby R. Maldini, Yanjie Yi, Irina Kulikovskaya, Farida Shaheen, Michael C. Holmes, Anthony Secreto, Jianbin Wang, Aimee S. Payne, Rachel S. Leibman, Sarah R. Akkina, Max W. Richardson
Publikováno v:
PLoS Pathogens, Vol 13, Iss 10, p e1006613 (2017)
PLoS Pathogens
PLoS Pathogens
HIV is adept at avoiding naturally generated T cell responses; therefore, there is a need to develop HIV-specific T cells with greater potency for use in HIV cure strategies. Starting with a CD4-based chimeric antigen receptor (CAR) that was previous
Autor:
Jianbin Wang, Josephine Romano, Beth S. Haggarty, Michael C. Holmes, James A. Hoxie, James L. Riley, Kevin Hua, Kritika E. Kumar, Andrea P. O. Jordon, George J. Leslie, Max W. Richardson, Philip D. Gregory, Anthony Secreto, Carl H. June, Jennifer Duong, Joshua J. DeClercq, Michael J. Root
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
PLoS Pathogens, Vol 12, Iss 11, p e1005983 (2016)
HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion. Inhibition has also been seen when these peptides are conjugated to anchoring molecules and
Autor:
David L. Bajor, Katelyn T. Byrne, Max W. Richardson, Timothy Chao, Jeffrey H. Lin, James L. Riley, Robert H. Vonderheide, Rebecca A. Evans, Ben Z. Stanger, Andrew J. Rech, Rafael Winograd, Mark S. Diamond, Nune Markosyan
Publikováno v:
JCI Insight. 1
In carcinogen-driven cancers, a high mutational burden results in neoepitopes that can be recognized immunologically. Such carcinogen-induced tumors may evade this immune response through “immunoediting,” whereby tumors adapt to immune pressure a
Publikováno v:
The Journal of Immunology. 189:3815-3821
CCR5, a cell surface molecule critical for the transmission and spread of HIV-1, is dynamically regulated during T cell activation and differentiation. The molecular mechanism linking T cell activation to modulation of CCR5 expression remains undefin